Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPARE: Coreg CR vs Coreg IR in Stable Chronic Heart Failure
NCT00323037Phase 3Completed
- Sponsor
- CTI Clinical Trial and Consulting Services
- Start
- Mar 2006
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of carvedilol in heart failure (HF) (2 arms), sponsored by CTI Clinical Trial and Consulting Services. Primary endpoint: Change From Baseline in Left Ventricular End Systolic Volume Index at 24 weeks. Started Mar 2006; status: completed.
02
Drugs
carvedilol
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00323037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323037.